Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Kalinox inhalation sedation for therapeutic dental procedures in community dental practice
2006-005691-40Phase 3Completed
- Sponsor
- Air Liquide Healthcare
- Start
- Aug 2007
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of nitrous oxide + oxygen in Dental anxiety and None, sponsored by Air Liquide Healthcare. Primary endpoint: Procedural success rate. Started Aug 2007; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on 2006-005691-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005691-40.